Aspira Historical Cash Flow
| AWH Stock | USD 0.81 0.05 6.58% |
Analysis of Aspira Womens cash flow over time is an excellent tool to project Aspira Womens Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 16.8 M or Other Cashflows From Financing Activities of 4.2 M as it is a great indicator of Aspira Womens ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Aspira Womens Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aspira Womens Health is a good buy for the upcoming year.
Aspira |
About Aspira Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Aspira balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aspira's non-liquid assets can be easily converted into cash.
Aspira Womens Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Aspira Womens Health to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aspira Womens operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Aspira Womens' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aspira Womens Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. As of now, Aspira Womens' Change To Inventory is increasing as compared to previous years. The Aspira Womens' current Begin Period Cash Flow is estimated to increase to about 16.8 M, while Change In Cash is forecasted to increase to (10.2 M).
| 2023 | 2024 (projected) | Dividends Paid | 847.8K | 805.4K | Stock Based Compensation | 1.7M | 1.7M |
Aspira Womens cash flow statement Correlations
Click cells to compare fundamentals
Aspira Womens Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aspira Womens cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 67K | (5K) | (144K) | (142K) | 89K | 93.5K | |
| Change In Cash | 2.3M | 4.9M | 20.8M | (23.9M) | (10.7M) | (10.2M) | |
| Change In Working Capital | 691K | 1.3M | 1.4M | (2.6M) | (155K) | (162.8K) | |
| Begin Period Cash Flow | 9.4M | 11.7M | 16.6M | 37.4M | 13.6M | 16.8M | |
| Other Cashflows From Financing Activities | 2.1M | 6.3M | 341K | 7.7M | 5.4M | 4.2M | |
| Depreciation | 333K | 265K | 302K | 264K | 199K | 189.1K | |
| Other Non Cash Items | 54K | 26K | 37K | (5.4M) | (717K) | (752.9K) | |
| Capital Expenditures | 133K | 490K | 184K | 232K | 24K | 22.8K | |
| Total Cash From Operating Activities | (13.0M) | (14.7M) | (27.4M) | (32.2M) | (15.9M) | (16.7M) | |
| Net Income | (15.2M) | (17.9M) | (31.7M) | (27.2M) | (16.7M) | (17.5M) | |
| Total Cash From Financing Activities | 15.4M | 20.2M | 48.4M | 7.4M | 5.2M | 5.0M | |
| End Period Cash Flow | 11.7M | 16.6M | 37.4M | 13.6M | 2.9M | 2.7M | |
| Sale Purchase Of Stock | 942K | 13.5M | 15.6M | 17.3M | 19.9M | 20.9M | |
| Stock Based Compensation | 1.2M | 1.5M | 3.5M | 2.4M | 1.7M | 1.7M | |
| Change To Account Receivables | (138K) | 59K | (162K) | (218K) | (214K) | (224.7K) | |
| Total Cashflows From Investing Activities | (113K) | (132K) | (490K) | (184K) | (211.6K) | (222.2K) | |
| Change To Operating Activities | (92K) | (209K) | (319K) | (548K) | (630.2K) | (661.7K) | |
| Investments | (132K) | (490K) | (184K) | (232K) | (86K) | (90.3K) | |
| Net Borrowings | (214K) | (189K) | 2.8M | (198K) | (178.2K) | (169.3K) | |
| Change To Netincome | 1.1M | 1.2M | 1.6M | 2.6M | 2.3M | 2.2M | |
| Change To Liabilities | 50K | 380K | 971K | 1.6M | 2.2M | 0.0 | |
| Issuance Of Capital Stock | 13.5M | 10.6M | 48.2M | 9M | 202K | 191.9K |
Currently Active Assets on Macroaxis
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.